Exhibiting at FOOD INGREDIENTS CHINA 2025

Ningxia Qiyuan Pharmaceutical Co., Ltd., headquartered in Yinchuan, Ningxia Hui Autonomous Region, China, is a leading pharmaceutical manufacturer and exporter specializing in the production of Active Pharmaceutical Ingredients (APIs), veterinary drugs, and vitamin compounds. With a strong foundation in fermentation and chemical synthesis, Qiyuan Pharmaceutical has positioned itself as a key supplier of macrolide antibiotics and essential vitamins to markets worldwide.

Core Business and Offerings

Ningxia Qiyuan Pharmaceutical is engaged in the research, production, and export of a wide range of high-quality pharmaceutical ingredients, with a focus on macrolides, tetracyclines, and fermentation-based compounds.

Product Portfolio

• Macrolide Antibiotics

  • Erythromycin Base
  • Erythromycin Thiocyanate
  • Azithromycin
  • Clarithromycin

• Tetracyclines

  • Tetracycline Hydrochloride
  • Tetracycline Base

• Vitamins

  • Vitamin C (Ascorbic Acid) and its derivatives

• Antiparasitic Compounds

  • Avermectin (used in veterinary and agricultural sectors)

These products are used in the formulation of human and veterinary drugs, and are supplied to pharmaceutical companies, formulation plants, and distributors around the world.

Specialization and Unique Value Proposition

Qiyuan Pharmaceutical is recognized for its fermentation-based macrolide API production, making it one of China’s more technically advanced producers of Erythromycin derivatives. Its competitive advantages include:

• Vertical integration from raw material fermentation to final API crystallization
• cGMP-compliant production facilities
• Stable export-quality product consistency
• Multi-compound manufacturing capability within a single industrial zone

The company also engages in custom synthesis and contract manufacturing for global clients seeking reliable Chinese partners for cost-efficient API production.

Financial and Operational Scale

While specific financial data is not publicly disclosed, Ningxia Qiyuan Pharmaceutical operates at a large industrial scale, with:

• Multiple API production lines
• In-house fermentation tanks and synthesis reactors
• Distribution of thousands of metric tons of API products annually
• Presence in both domestic hospital procurement chains and international bulk pharmaceutical markets

Its long-standing presence in China's pharmaceutical industry reflects both financial stability and manufacturing capability.

Export and Shipment Insights

Qiyuan Pharmaceutical has a proven export track record across major global markets, including:

• India – Supplying bulk erythromycin and tetracycline APIs
• South America – For veterinary applications
• Middle East and Southeast Asia – For human-use antibiotics and vitamin C formulations
• Africa – Via government health procurement partners

Products are shipped in pharma-grade drums or fiberboard containers, with complete documentation including CoA, DMF, GMP certificates, and batch-specific microbial and impurity analysis.

Target Market

The company’s products cater to:

• Generic pharmaceutical manufacturers
• Veterinary pharmaceutical companies
• Nutraceutical and dietary supplement firms
• API traders and importers
• Contract formulators and CMOs

It supplies to markets requiring both USP, BP, and EP-grade APIs, and custom regulatory filings for specific country-level approvals.

Capabilities

• Large-scale microbial fermentation technology
• Chemical synthesis and purification of complex antibiotics
• Vitamin derivative crystallization and stabilization
• In-house QC/QA labs with HPLC, GC-MS, and microbiological testing
• Regulatory documentation and global DMF support

The company also has R&D programs focused on macrolide derivative improvements and next-generation anti-infectives.

Certifications and Compliance

Ningxia Qiyuan Pharmaceutical holds certifications and complies with:

• Chinese GMP certification for API production
• ISO 9001 Quality Management System
• Halal certification for select products
• DMF filings for various countries
• REACH and RoHS declarations for applicable chemical exports

Products are manufactured in accordance with WHO guidelines and pharmacopeial standards for global compliance.

Customer Testimonials and Industry Reputation

While direct testimonials are not publicly listed, Qiyuan Pharmaceutical has earned recognition in:

• Pharmaceutical buyer directories
• Government export compliance audits
• API supply contract renewals with multinational pharma firms

It is considered a trusted secondary supplier for erythromycin globally, often used by companies as a backup or supplementary vendor due to its consistent product quality and batch traceability.

Key Achievements

• Exported APIs to over 30 countries across Asia, Africa, South America, and Eastern Europe
• Developed complete manufacturing platforms for Erythromycin and Vitamin C
• Integrated fermentation and chemical synthesis to reduce production costs and improve sustainability
• Participated in Chinese pharmaceutical export exhibitions and government trade programs
• Supported public health and animal health sectors through reliable antibiotic ingredient supply

Ningxia Qiyuan Pharmaceutical Co., Ltd. continues to be a critical player in China’s pharmaceutical export ecosystem, offering cost-effective, high-quality API solutions that meet the needs of the global healthcare and veterinary markets.